Cargando…
An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells
Measles virus envelope pseudotyped LV (MV-LV) can achieve high B cell transduction rates (up to 50%), but suffers from low titers. To overcome current limitations, we developed an optimized MV-LV production protocol that achieved consistent B cell transduction efficiency up to 75%. We detail this pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914380/ https://www.ncbi.nlm.nih.gov/pubmed/35284833 http://dx.doi.org/10.1016/j.xpro.2022.101228 |
_version_ | 1784667693898530816 |
---|---|
author | Vamva, Eirini Ozog, Stosh Verhoeyen, Els James, Richard G. Rawlings, David J. Torbett, Bruce E. |
author_facet | Vamva, Eirini Ozog, Stosh Verhoeyen, Els James, Richard G. Rawlings, David J. Torbett, Bruce E. |
author_sort | Vamva, Eirini |
collection | PubMed |
description | Measles virus envelope pseudotyped LV (MV-LV) can achieve high B cell transduction rates (up to 50%), but suffers from low titers. To overcome current limitations, we developed an optimized MV-LV production protocol that achieved consistent B cell transduction efficiency up to 75%. We detail this protocol along with analytical assays to assess the results of MV-LV mediated B cell transduction, including flow cytometry for B cell phenotypic characterization and measurement of transduction efficiency, and ddPCR for VCN analysis. |
format | Online Article Text |
id | pubmed-8914380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-89143802022-03-12 An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells Vamva, Eirini Ozog, Stosh Verhoeyen, Els James, Richard G. Rawlings, David J. Torbett, Bruce E. STAR Protoc Protocol Measles virus envelope pseudotyped LV (MV-LV) can achieve high B cell transduction rates (up to 50%), but suffers from low titers. To overcome current limitations, we developed an optimized MV-LV production protocol that achieved consistent B cell transduction efficiency up to 75%. We detail this protocol along with analytical assays to assess the results of MV-LV mediated B cell transduction, including flow cytometry for B cell phenotypic characterization and measurement of transduction efficiency, and ddPCR for VCN analysis. Elsevier 2022-03-08 /pmc/articles/PMC8914380/ /pubmed/35284833 http://dx.doi.org/10.1016/j.xpro.2022.101228 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Protocol Vamva, Eirini Ozog, Stosh Verhoeyen, Els James, Richard G. Rawlings, David J. Torbett, Bruce E. An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title | An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title_full | An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title_fullStr | An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title_full_unstemmed | An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title_short | An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells |
title_sort | optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary b cells |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914380/ https://www.ncbi.nlm.nih.gov/pubmed/35284833 http://dx.doi.org/10.1016/j.xpro.2022.101228 |
work_keys_str_mv | AT vamvaeirini anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT ozogstosh anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT verhoeyenels anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT jamesrichardg anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT rawlingsdavidj anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT torbettbrucee anoptimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT vamvaeirini optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT ozogstosh optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT verhoeyenels optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT jamesrichardg optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT rawlingsdavidj optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells AT torbettbrucee optimizedmeaslesvirusglycoproteinpseudotypedlentiviralvectorproductionsystemtopromoteefficienttransductionofhumanprimarybcells |